NO20055098L - Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser - Google Patents

Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser

Info

Publication number
NO20055098L
NO20055098L NO20055098A NO20055098A NO20055098L NO 20055098 L NO20055098 L NO 20055098L NO 20055098 A NO20055098 A NO 20055098A NO 20055098 A NO20055098 A NO 20055098A NO 20055098 L NO20055098 L NO 20055098L
Authority
NO
Norway
Prior art keywords
treatment
affective disorders
compound
dihydrocarbamazepine
hydroxy
Prior art date
Application number
NO20055098A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055098D0 (no
Inventor
Markus Schmutz
Ferenc Martenyl
Stefanie Zechner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055098D0 publication Critical patent/NO20055098D0/no
Publication of NO20055098L publication Critical patent/NO20055098L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO20055098A 2003-04-02 2005-11-01 Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser NO20055098L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45986403P 2003-04-02 2003-04-02
PCT/EP2004/003590 WO2004087168A1 (en) 2003-04-02 2004-04-01 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders

Publications (2)

Publication Number Publication Date
NO20055098D0 NO20055098D0 (no) 2005-11-01
NO20055098L true NO20055098L (no) 2005-12-22

Family

ID=33131906

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055098A NO20055098L (no) 2003-04-02 2005-11-01 Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser

Country Status (18)

Country Link
US (1) US20070010508A1 (pt)
EP (1) EP1613329A1 (pt)
JP (1) JP2006522064A (pt)
KR (1) KR20050121235A (pt)
CN (1) CN1767834A (pt)
AU (1) AU2004226827B2 (pt)
BR (1) BRPI0409151A (pt)
CA (1) CA2520828A1 (pt)
IS (1) IS8094A (pt)
MA (1) MA27762A1 (pt)
MX (1) MXPA05010614A (pt)
NO (1) NO20055098L (pt)
NZ (1) NZ542555A (pt)
RU (1) RU2367440C2 (pt)
TN (1) TNSN05246A1 (pt)
TW (1) TW200502222A (pt)
WO (1) WO2004087168A1 (pt)
ZA (1) ZA200507742B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
EP2380575B1 (en) * 2005-05-06 2015-02-25 Bial-Portela & CA, S.A. Eslicarbazepine acetate and use
MX2007013882A (es) * 2005-05-06 2008-01-28 Portela & Ca Sa Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso.
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
GB2437078A (en) * 2006-04-11 2007-10-17 Portela & Ca Sa 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
KR20100113163A (ko) * 2008-02-13 2010-10-20 타가셉트 인코포레이티드 알파 ７ 니코틴 작용제 및 항정신병제의 조합
ES2610356T3 (es) 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
US8680050B2 (en) 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
CN102188432B (zh) * 2011-04-07 2012-05-23 江立富 一种用于防治癫痫的药物
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
EP3042902B1 (en) 2013-09-06 2018-10-10 Nippon Soda Co., Ltd. Method for producing endo-9-azabicyclo[3.3.1]nonan-3-ol derivative
EP3064490A1 (en) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
PT101732B (pt) 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE10036289A1 (de) 2000-07-26 2002-02-07 Bosch Gmbh Robert Elektronisch kommutierte elektrische Maschine, insbesondere Motor
ES2314111T3 (es) * 2001-11-12 2009-03-16 Novartis Ag Monohidroxicarbamezepina para uso en la preparacion de un medicamento para el tratamiento del trastorno de afectivo y de atencion y dolor neuropatico.

Also Published As

Publication number Publication date
MXPA05010614A (es) 2005-11-23
AU2004226827A1 (en) 2004-10-14
TW200502222A (en) 2005-01-16
KR20050121235A (ko) 2005-12-26
US20070010508A1 (en) 2007-01-11
WO2004087168A1 (en) 2004-10-14
MA27762A1 (fr) 2006-02-01
NO20055098D0 (no) 2005-11-01
AU2004226827B2 (en) 2008-04-03
RU2005133665A (ru) 2006-06-10
BRPI0409151A (pt) 2006-03-28
CN1767834A (zh) 2006-05-03
EP1613329A1 (en) 2006-01-11
CA2520828A1 (en) 2004-10-14
RU2367440C2 (ru) 2009-09-20
JP2006522064A (ja) 2006-09-28
NZ542555A (en) 2009-03-31
TNSN05246A1 (en) 2007-06-11
IS8094A (is) 2005-10-27
ZA200507742B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
NO20055098L (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
NO20062691L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
NO20062689L (no) Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer
NO20062704L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
SE0302760D0 (sv) New compounds
NO20045072L (no) Tablett med hoyt medikamentinnhold
NO20082496L (no) Pyrazinderivater
NO20063382L (no) Nye kinolinderivater
EA200500088A1 (ru) Трициклические модуляторы ядерного рецептора стероидного гормона
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
ATE202346T1 (de) Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
EE05103B1 (et) Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid
NO20073730L (no) Amidderivater
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
SE9901573D0 (sv) New compounds
NO20040881L (no) Orale antidiabetes midler.
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
NO20032261L (no) Medisinske preparater
HUP0104963A2 (hu) Bőrbetegségek kezelésére szolgáló készítmények
CA2314154A1 (en) Azepine or larger medium ring derivatives and their use as pharmaceuticals
NO308654B1 (no) Amid-derivater, fremgangsmÕter og mellomprodukter for fremstilling derav, deres anvendelse og farmasøytiske blandinger som inneholdende dem
NO20062401L (no) Anvendelse av et hydroksimsyrehalidderivat i behandling av neurodegenerative sykdommer
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application